The cellular and molecular basis of heart failure in regurgitant valvular diseases: the myocardial extracellular matrix as a building block for future therapy.
Borer
Jeffrey S
JS
Division of Cardiovascular Pathophysiology, Department of Cardiothoracic Surgery and Howard Gilman Institute for Valvular Heart Diseases, Weill Medical College of Cornell University, New York, N.Y., USA.
Truter
Sharada L
SL
Herrold
Edmund McM
EM
Supino
Phyllis G
PG
Carter
John N
JN
Gupta
Anuj
A
D001022:Aortic Valve Insufficiency / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D005109:Extracellular Matrix / Q000473:pathology; D005544:Forecasting; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006349:Heart Valve Diseases / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D009206:Myocardium / Q000166:cytology / Q000473:pathology; D013318:Stroke Volume / Q000502:physiology; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000503:physiopathology / Q000628:therapy